Maria Domercq Selected Research

Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)

1/2018	In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia.
1/2016	PET Imaging with [(18)F]FSPG Evidences the Role of System xc(-) on Brain Inflammation Following Cerebral Ischemia in Rats.
4/2015	In vivo PET imaging of the α4β2 nicotinic acetylcholine receptor as a marker for brain inflammation after cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Domercq Research Topics

Disease

4	Ischemia 01/2023 - 04/2010
3	Stroke (Strokes) 01/2023 - 04/2010
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018 - 04/2015
2	Hypoxia (Hypoxemia) 01/2023 - 03/2013
2	Brain Diseases (Brain Disorder) 01/2023 - 01/2016
2	Brain Ischemia (Cerebral Ischemia) 01/2018 - 04/2015
2	Neuroinflammatory Diseases 01/2018 - 04/2015
2	Multiple Sclerosis 06/2016 - 04/2011
1	Fatigue 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2016
1	Ischemic Stroke 04/2015
1	Encephalitis (Encephalitis, Rasmussen) 04/2015
1	Reperfusion Injury 03/2013
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2010

Drug/Important Bio-Agent (IBA)

5	Glutamic Acid (Glutamate)FDA Link 06/2016 - 04/2010
3	Adenosine Triphosphate (ATP)IBA 01/2023 - 04/2010
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2013
2	Oxygen (Dioxygen)IBA 01/2023 - 03/2013
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2018 - 04/2015
2	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2018 - 01/2016
2	PK 11195 (PK11195)IBA 06/2016 - 04/2015
1	CC ChemokinesIBA 01/2023
1	Macrophage Colony-Stimulating FactorIBA 01/2023
1	Lysosomal-Associated Membrane Protein 1IBA 01/2023
1	Hanks Balanced Salt SolutionIBA 01/2023
1	Beclin-1IBA 01/2023
1	Sirolimus (Rapamycin)FDA Link 01/2023
1	DAPIIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Cysteine (L-Cysteine)FDA Link 01/2023
1	ChemokinesIBA 01/2023
1	Caspase 3 (Caspase-3)IBA 01/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	CytokinesIBA 01/2020
1	4- (5- (1- methyl- 1H- pyrrol- 2- yl)- 1,3,4- oxadiazol- 2- yl)- 1,4- diazabicyclo(3.2.2)nonaneIBA 01/2018
1	PHA-568487EIBA 01/2018
1	Deoxyglucose (2 Deoxy D glucose)IBA 06/2016
1	Cystine (L-Cystine)IBA 01/2016
1	ArginaseIBA 01/2016
1	LigandsIBA 01/2016
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2016
1	AntiportersIBA 01/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2013
1	Glucose (Dextrose)FDA LinkGeneric 03/2013
1	U 0126 (UO 126)IBA 03/2013
1	N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA 03/2013
1	6- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)IBA 03/2013
1	AntioxidantsIBA 03/2013
1	EnzymesIBA 04/2010
1	Purinergic P2X7 ReceptorsIBA 04/2010
1	Apyrase (ATP Diphosphatase)IBA 04/2010

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2016
1	Cranial Irradiation 01/2023